0001139685-16-000007.txt : 20160204 0001139685-16-000007.hdr.sgml : 20160204 20160204142857 ACCESSION NUMBER: 0001139685-16-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160204 DATE AS OF CHANGE: 20160204 EFFECTIVENESS DATE: 20160204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 20/20 GeneSystems, Inc. CENTRAL INDEX KEY: 0001139685 IRS NUMBER: 522272107 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-256733 FILM NUMBER: 161387970 BUSINESS ADDRESS: STREET 1: 9430 KEY WEST AVENUE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2404536339 MAIL ADDRESS: STREET 1: 9430 KEY WEST AVENUE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: 20/20 GENE SYSTEMS INC DATE OF NAME CHANGE: 20010502 D 1 primary_doc.xml X0707 D LIVE 0001139685 20/20 GeneSystems, Inc. 9430 KEY WEST AVENUE SUITE 100 ROCKVILLE MD MARYLAND 20850 2404536339 DELAWARE 20/20 GENE SYSTEMS INC Corporation true Jonathan Cohen 9430 Key West Avenue Suite 100 Rockville MD MARYLAND 20850 Executive Officer Director President, CEO and Director Joel Kanter 9430 Key West Avenue Suite 100 Rockville MD MARYLAND 20850 Executive Officer Director Donald Wallach 9430 Key West Avenue Suite 100 Rockville MD MARYLAND 20850 Director Vladimir Knezevic 9430 Key West Avenue Suite 100 Rockville MD MARYLAND 20850 Director Dean Hautamaki 9430 Key West Avenue Suite 100 Rockville MD MARYLAND 20850 Director Caroline Popper 9430 Key West Avenue Suite 100 Rockville MD MARYLAND 20850 Director Biotechnology Decline to Disclose 06b false 2016-01-28 false true false 50000 3000000 2000000 1000000 false 1 0 0 150000 true A portion of the proceeds of the offering may in the future be used as part of the compensation package for certain of the issuer's executive officers in the form of cash or equity. $150,000 assumes the full offering amount of $3,000,000 is raised. false 20/20 GeneSystems, Inc. /s/ Jonathan Cohen Jonathan Cohen President & CEO 2016-02-04